Clicky

Immutep Limited(IMMP) News

Date Title
Jul 28 Immutep Announces Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
Jul 24 High Growth Tech Stocks To Watch In Australia July 2025
Jul 22 High Growth Tech Stocks in Australia for July 2025
Jul 21 Exploring Three High Growth Tech Stocks in Australia
Jul 20 High Growth Tech Stocks in Australia Featuring Life360 and Two Others
Jul 13 High Growth Tech Stocks in Australia July 2025
Jul 2 Exploring Three High Growth Tech Stocks In Australia
Jun 29 Immutep (IMMP) Announces Positive Initial Efficacy Data and Continued Favourable Safety Data
Jun 26 ASX Penny Stocks Spotlight: Arafura Rare Earths And Two More To Consider
Jun 23 High Growth Tech Stocks In Australia For June 2025
Jun 23 Immutep Announces Positive Update from Phase I Study of IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases
Jun 19 Exploring Life360 And 2 Prominent High Growth Tech Stocks In Australia
May 27 Immutep’s Efti with Radiotherapy & KEYTRUDA® (pembrolizumab) Meets Primary Endpoint in Phase II for Soft Tissue Sarcoma
Mar 10 Immutep Limited (IMMP): Among the Best Australian Stocks to Buy According to Billionaires
Oct 10 Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit
Oct 4 Immutep concludes participant enrolment in Phase II breast cancer trial
Oct 3 Immutep Completes Patient Enrolment in Randomised Phase II of AIPAC-003 Trial in Metastatic Breast Cancer
Sep 24 Immutep Receives A$3.6 million R&D Tax Incentive from French Government
Aug 14 Immutep Announces First Participant Dosed in Phase I Study of IMP761, a First in Class Agonist LAG-3 Antibody
Jul 31 Immutep Quarterly Activities Report Q4 FY24